John E. Smart
27Patents
11h-index
33Co-inventors
75Inventor score
Filing activity: May 19, 1987 → Jun 13, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6627228B1 | Polymeric delivery agents and delivery agents compounds | Chemistry; Metallurgy | 82 | Expired |
| US6093547A | Morphogen cell surface receptor and screening for morphogen analogs | Emerging Cross-Sectional Technologies | 66 | Expired |
| US6333312A | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases | Physics | 23 | Expired |
| US6090776A | Morphogen treatment of organ implants | Physics | 20 | Expired |
| US5741641A | Morphogenic protein screening method | Physics | 20 | Expired |
| US6440929B1 | Pulmonary delivery of active agents | Human Necessities | 17 | Expired |
| US5739107A | Morphogen treatment of gastrointestinal ulcers | Physics | 16 | Expired |
| US6693073B2 | Pulmonary delivery of active agents | Human Necessities | 15 | Expired |
| US5650276A | Morphogenic protein screening method | Physics | 15 | Expired |
| US6040431A | Single chain analogs of the TGF-.beta. superfamily (morphons) | Chemistry; Metallurgy | 14 | Expired |
| US7727558B2 | Polymeric delivery agents and delivery agent compounds | Chemistry; Metallurgy | 11 | Active |
| US8410309B2 | Phenoxy carboxylic acid compounds and compositions for delivering active agents | Chemistry; Metallurgy | 11 | Active |
| US6399569B1 | Morphogen treatments for limiting proliferation of epithelial cells | Physics | 9 | Expired |
| US6077823A | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury | Physics | 8 | Expired |
| US6949505B1 | Morphogen-induced dendritic growth | Human Necessities | 7 | Expired |
| US6479643B1 | Single chain analogs of the TGF-&bgr; superfamily (morphons) | Chemistry; Metallurgy | 5 | Expired |
| US7056882B2 | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases | Human Necessities | 5 | Expired |
| US5707810A | Method of diagnosing renal tissue damage or disease | Physics | 5 | Expired |
| US7129274B1 | Phenoxy carboxylic acid compounds and compositions for delivering active agents | Chemistry; Metallurgy | 4 | Expired |
| US5162503A | Purification of interleukin-2 by receptor-affinity chromatography | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5149788A | Purification of chimeric proteins containing an IL-2 moiety by receptor-affinity chromatography | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5994131A | Morphogenic protein screening method | Physics | 3 | Expired |
| US5861479A | Morphogen cell surface receptor | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7208483B2 | Polymeric delivery agents and delivery agent compounds | Chemistry; Metallurgy | 2 | Expired |
| US5831050A | Morphogen cell surface receptor | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.